<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJS</journal-id>
<journal-id journal-id-type="hwp">spijs</journal-id>
<journal-id journal-id-type="nlm-ta">Int J Surg Pathol</journal-id>
<journal-title>International Journal of Surgical Pathology</journal-title>
<issn pub-type="ppub">1066-8969</issn>
<issn pub-type="epub">1940-2465</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage CA: Los Angeles, CA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/1066896912453202</article-id>
<article-id pub-id-type="publisher-id">10.1177_1066896912453202</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Case Reports</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epiphyseal Ewing Sarcoma</article-title>
<subtitle>First Reported Case With Molecular Confirmation</subtitle>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Pérez-González</surname><given-names>Yosmar</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff1-1066896912453202">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>García-Esparza</surname><given-names>Elena</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff2-1066896912453202">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Conde</surname><given-names>Esther</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff3-1066896912453202">3</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Azorín</surname><given-names>Daniel</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="aff4-1066896912453202">4</xref>
</contrib>
</contrib-group>
<aff id="aff1-1066896912453202"><label>1</label>Department of Surgical Pathology, Hospital Universitario de Móstoles, Madrid, Spain</aff>
<aff id="aff2-1066896912453202"><label>2</label>Department of Radiology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain</aff>
<aff id="aff3-1066896912453202"><label>3</label>Department of Pathology, Hospital Universitario Madrid Sanchinarro, Madrid, Spain</aff>
<aff id="aff4-1066896912453202"><label>4</label>Department of Surgical Pathology, Hospital Infantil Universitario Niño Jesús, Madrid, Spain</aff>
<author-notes>
<corresp id="corresp1-1066896912453202">Daniel Azorín, Hospital Infantil Universitario Niño Jesús, Avda. Menendez Pelayo, 65, Madrid 28009, Spain Email: <email>dazorin.hnjs@salud.madrid.org</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>21</volume>
<issue>2</issue>
<fpage>173</fpage>
<lpage>176</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Ewing sarcoma is the second most common pediatric malignant bone neoplasm after osteosarcoma. Ewing sarcoma comprises “small, round, blue-cell” tumors thought to arise from neural crest cells. The authors report the case of a 14-year-old boy that presented with a nonpainful circumscribed lesion. The radiographs showed a lytic lesion at the tibial epiphysis with a large soft tissue mass, best depicted in the magnetic resonance imaging scan that suggested an aggressive lesion. A needle biopsy of the lesion was performed. The diagnosis of Ewing sarcoma was made based on microscopic, immunohistochemical, polymerase chain reaction, and fluorescence in situ hybridization. This is the third case report about a primary epiphyseal Ewing sarcoma and the fist one with molecular confirmation.</p>
</abstract>
<kwd-group>
<kwd>Ewing sarcoma</kwd>
<kwd>bone tumor</kwd>
<kwd>primitive neuroectodermal tumor</kwd>
<kwd>epiphysis</kwd>
<kwd>magnetic resonance imaging</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="section1-1066896912453202" sec-type="intro">
<title>Introduction</title>
<p>The World Health Organization defined Ewing sarcoma and primitive neuroectodermal tumor (PNET) as
<disp-quote>
<p>round cell sarcomas that show varying degrees of neuroectodermal differentiation. The term Ewing sarcoma has been used for those tumors that lack evidence of neuroectodermal differentiation as assessed by light microscopy, immunohistochemistry and electron microscopy, whereas the term PNET has been employed for tumors that demonstrate neuroectodermal features as evaluated by one or more of these modalities.<sup><xref ref-type="bibr" rid="bibr1-1066896912453202">1</xref>(p298)</sup></p>
</disp-quote></p>
<p>Ewing sarcoma is the second most common pediatric malignant bone neoplasm after osteosarcoma.<sup><xref ref-type="bibr" rid="bibr2-1066896912453202">2</xref>,<xref ref-type="bibr" rid="bibr3-1066896912453202">3</xref></sup> They comprise “small, round, blue-cell” tumors thought to arise from neural crest cells. Together with the malignant peripheral neuroectodermal tumors, they now make up Ewing’s sarcoma family of tumors (ESFT).<sup><xref ref-type="bibr" rid="bibr2-1066896912453202">2</xref>,<xref ref-type="bibr" rid="bibr3-1066896912453202">3</xref></sup> The skeletal distribution of Ewing sarcoma is evenly distributed between the axial and appendicular skeleton, and in the long bones, the diaphysis is the more typical location.<sup><xref ref-type="bibr" rid="bibr2-1066896912453202">2</xref>,<xref ref-type="bibr" rid="bibr3-1066896912453202">3</xref></sup> Solitary involvement of the epiphysis in these tumors is rare and may lead to diagnostic and therapeutic error.<sup><xref ref-type="bibr" rid="bibr4-1066896912453202">4</xref>,<xref ref-type="bibr" rid="bibr5-1066896912453202">5</xref></sup> Epiphyseal tumors have a very low incidence.<sup><xref ref-type="bibr" rid="bibr6-1066896912453202">6</xref></sup> The condroblastoma is the most frequent bone tumor located in the epiphyses in children.<sup><xref ref-type="bibr" rid="bibr6-1066896912453202">6</xref></sup> To the best of our knowledge, only 2 cases of primary epiphyseal localization of PNET/Ewing sarcoma in a child have been previously reported.<sup><xref ref-type="bibr" rid="bibr4-1066896912453202">4</xref>,<xref ref-type="bibr" rid="bibr5-1066896912453202">5</xref></sup></p>
</sec>
<sec id="section2-1066896912453202" sec-type="cases">
<title>Case Report</title>
<p>A 14-year-old boy presented since May 2010 with a 3-month history of a nonpainful, circumscribed lesion in his right ankle that had continued to grow in size gradually. Since August 2010, he referred with pain and was originally treated with nonsteroidal medication for several weeks. Plain radiographs were performed as the symptoms did not improve (<xref ref-type="fig" rid="fig1-1066896912453202">Figure 1</xref>). They showed a small ill-defined moth-eaten lytic lesion at the tibial epiphysis. There was a solid periosteal reaction in the tibial metaphysis and diaphysis and a big soft tissue mass. The magnetic resonance imaging scan (<xref ref-type="fig" rid="fig2-1066896912453202">Figure 2</xref>) showed infiltration of bone only at the tibial epiphysis and a bulky soft tissue mass in the posterior aspect of the ankle. The mass had very well-defined margins and a very homogeneous signal, intermediate in T1WI and not very high in T2WI, and grew surrounding the tendons and fascia, encasing but not infiltrating the structures. The presence of such a big soft tissue mass with osseous involvement lead to think of an aggressive lesion, and a needle biopsy was performed. Macroscopically, it was a soft-tissue core of 1 cm in length. Microscopic examination of the biopsy specimen showed a diffuse growth of small, poorly differentiated cells with round nuclei containing fine chromatin and scant cytoplasm (<xref ref-type="fig" rid="fig3-1066896912453202">Figure 3</xref>). Further testing including immunohistochemical staining showed that the tumor cells were diffusely positive for CD99 (<xref ref-type="fig" rid="fig4-1066896912453202">Figure 4</xref>) and negative for CD45. Finally, a diagnosis of Ewing sarcoma was made based on microscopic and immunohistochemical findings. Polymerase chain reaction (PCR) was negative for the commonest ESFT translocations, t(11;22) and t(21;22), but fluorescence in situ hybridization (FISH) showed rearrangement of EWS gene (<xref ref-type="fig" rid="fig5-1066896912453202">Figure 5</xref>). Extension study showed multiple lung nodules in the chest computed tomography scan. Bone scan and bone marrow biopsy were done and did not show neoplastic infiltration. The child was treated with the SEOP 2001 chemotherapy protocol but died from the disease 1 year later.</p>
<fig id="fig1-1066896912453202" position="float">
<label>Figure 1.</label>
<caption>
<p>Plain radiograph of the right ankle: anteroposterior (A) and lateral (B) views showing a lytic, moth-eaten lesion in the tibial distal malleolus (arrowhead) with diaphyseal solid reaction (arrow). A bulky soft tissue mass is seen posteriorly (asterisk)</p>
</caption>
<graphic xlink:href="10.1177_1066896912453202-fig1.tif"/></fig>
<fig id="fig2-1066896912453202" position="float">
<label>Figure 2.</label>
<caption>
<p>Magnetic resonance imaging scan of the right ankle. Sagital T1WI (A) shows epiphyseal involvement (asterisk) of the tumor and a big soft tissue mass. The signal intensity of the mass is intermediate in T1 (A and B) and not very high in T2 (C) and grows encasing but not infiltrating the tendons (arrows) and fascia</p>
</caption>
<graphic xlink:href="10.1177_1066896912453202-fig2.tif"/></fig>
<fig id="fig3-1066896912453202" position="float">
<label>Figure 3.</label>
<caption>
<p>Diffuse growth of small, poorly differentiated cells with round nuclei containing fine chromatin and scant cytoplasm (hemotoxylin–eosin, 40×)</p>
</caption>
<graphic xlink:href="10.1177_1066896912453202-fig3.tif"/></fig>
<fig id="fig4-1066896912453202" position="float">
<label>Figure 4.</label>
<caption>
<p>The tumor cells showed diffusely positive membranous staining for CD99 (CD99, 40×)</p>
</caption>
<graphic xlink:href="10.1177_1066896912453202-fig4.tif"/></fig>
<fig id="fig5-1066896912453202" position="float">
<label>Figure 5.</label>
<caption>
<p>Tumor hybridized with the Vysis EWSR1 break-apart FISH probe (Abbott Molecular, Des Plaines, IL). The tumor cells show the 1 fusion, 1 orange, and 1 green signal pattern indicative of rearrangement of EWSR1</p>
</caption>
<graphic xlink:href="10.1177_1066896912453202-fig5.tif"/></fig>
</sec>
<sec id="section3-1066896912453202" sec-type="discussion">
<title>Discussion</title>
<p>Ewing sarcoma has an incidence of 1 to 2 cases/million per year.<sup><xref ref-type="bibr" rid="bibr2-1066896912453202">2</xref></sup> It is a tumor of adolescent age group, and males are affected slightly more often than females.<sup><xref ref-type="bibr" rid="bibr1-1066896912453202">1</xref>,<xref ref-type="bibr" rid="bibr5-1066896912453202">5</xref>,<xref ref-type="bibr" rid="bibr7-1066896912453202">7</xref></sup> Patients commonly present with pain or symptoms of osteomyelitis. Pathologic fracture can be found in about 10% to 15% of the cases.<sup><xref ref-type="bibr" rid="bibr2-1066896912453202">2</xref></sup> It usually arises in diaphyseal or metaphyseal regions in the form of an intramedullary lytic or lytic and sclerotic lesion with an aggressive lamellated periosteal reaction.<sup><xref ref-type="bibr" rid="bibr8-1066896912453202">8</xref></sup> Epiphyseal involvement may occur by extension from a primary metaphyseal or diaphyseal lesion.<sup><xref ref-type="bibr" rid="bibr4-1066896912453202">4</xref>,<xref ref-type="bibr" rid="bibr5-1066896912453202">5</xref>,<xref ref-type="bibr" rid="bibr9-1066896912453202">9</xref></sup></p>
<p>To the best of our knowledge, there are only 2 previous cases of epiphyseal Ewing sarcoma reported in the literature. The first was reported in 2003 by Muscolo et al, who published a case of a 13-year-old boy complaining of right knee pain, without a traumatic history. Radiographs showed a sclerotic lesion at the tibial epiphysis with no evidence of tumor extension to the soft tissues or the adjacent joint. Evaluation of metastatic disease was negative. The patient entered a chemotherapy protocol and after completing it a surgical resection of the upper end of the tibia was done. The histological diagnosis of Ewing sarcoma was made; however, the authors did not describe either the immunophenotype of the tumor or the molecular confirmation of such a diagnosis. The patient developed pulmonary metastases 10 months later and died.<sup><xref ref-type="bibr" rid="bibr4-1066896912453202">4</xref></sup> The second epiphyseal Ewing sarcoma was reported by Kowalczyk et al in 2011.<sup><xref ref-type="bibr" rid="bibr5-1066896912453202">5</xref></sup> They published the case of a 5-year-old girl with a history of 4 weeks of slight, intermittent limp favoring her right lower extremity without pain. Radiographs showed a large, lytic lesion in the left distal femoral epiphysis without periosteal reaction or cortex interruption, leading to an initial diagnosis of benign chondroblastoma. The patient underwent an open biopsy that revealed a diffuse growth of small, poorly differentiated cells, diffusely positive for CD99. However, cytogenetic examinations for the EWS-FLI-1 fusion gene were not performed. The child was treated with surgery and chemotherapy, remaining disease free after 2 years of follow-up.<sup><xref ref-type="bibr" rid="bibr2-1066896912453202">2</xref></sup> Our patient also showed a lytic lesion; however, unlike both previously reported cases, our patient had a big soft tissue mass, which raised the suspicion of a malignant tumor. The epiphyseal involvement, a lytic moth-eaten lesion, is that of an aggressive pattern, and the presence of a big soft tissue mass supported the idea of an aggressive tumor. The growth pattern of the soft tissue mass, encasing but not infiltrating structures, the homogeneous and not very high T2 signal, and the scarce infiltration of the bone lead to consider the diagnosis of a lymphoma.<sup><xref ref-type="bibr" rid="bibr10-1066896912453202">10</xref></sup> A synovial sarcoma was also considered, as it is the most common soft tissue sarcoma in the ankle and osseous extension is not uncommon.<sup><xref ref-type="bibr" rid="bibr11-1066896912453202">11</xref></sup> An aggressive appearing lesion in the bone associated with a big soft tissue mass always raises the suspicion of Ewing sarcoma, but the epiphyseal involvement in this case was misleading, as Ewing sarcoma is usually a diaphyseal tumor. Histologically, it showed the typical features of Ewing sarcoma, consisting of a uniform small round cell neoplasm, CD99 positive. In addition, unlike the previously reported cases, we have demonstrated the diagnostic EWS rearrangement by FISH. So, to the best of our knowledge, this is the first reported case of Ewing sarcoma in an epiphyseal location with molecular confirmation.</p>
<p>Epiphyseal primary location for Ewing sarcoma is very rare. Hovy<sup><xref ref-type="bibr" rid="bibr6-1066896912453202">6</xref></sup> did not find any primary malignancy in a series of 2758 epiphyseal bone tumors, with chondroblastoma being the most frequent tumor.<sup><xref ref-type="bibr" rid="bibr2-1066896912453202">2</xref>,<xref ref-type="bibr" rid="bibr4-1066896912453202">4</xref>,<xref ref-type="bibr" rid="bibr8-1066896912453202">8</xref></sup> However, in view of a small round cell tumor with radiological aggressive features, the histological differential diagnosis must include the group of the small round cell tumors such as neuroblastoma, small-cell osteosarcoma, mesenchymal chondrosarcoma, embryonal rhabdomyosarcoma, or lymphoblastic lymphoma.<sup><xref ref-type="bibr" rid="bibr1-1066896912453202">1</xref>,<xref ref-type="bibr" rid="bibr5-1066896912453202">5</xref>,<xref ref-type="bibr" rid="bibr12-1066896912453202">12</xref></sup> Immunohistochemistry will help make the diagnosis. Ewing sarcoma is positive for CD99, whereas neuroblastoma is negative.<sup><xref ref-type="bibr" rid="bibr2-1066896912453202">2</xref></sup> Embryonal rhabdomyosarcoma and lymphoblastic lymphoma may stain for CD99; however, myogenin and MyoD1 in the former and CD45 and Tdt in the latter will help us make a correct diagnosis. Immunostaining for CD99 does not allow distinction of small-cell osteosarcoma and mesenchymal chondrosarcoma, making necessary the molecular evidence for EWS rearrangement.<sup><xref ref-type="bibr" rid="bibr13-1066896912453202">13</xref>,<xref ref-type="bibr" rid="bibr14-1066896912453202">14</xref></sup> PCR is the gold standard to find any of the diagnostic translocations of Ewing sarcoma, but FISH analysis a using dual-color, break-apart EWS probe may be extremely useful,<sup><xref ref-type="bibr" rid="bibr15-1066896912453202">15</xref></sup> mainly when there has been inadequate material for PCR, as in our case.</p>
<p>To conclude, we think that although Ewing sarcoma is a very rare pathology in an epiphyseal location, we have to think about it any time a child has a lesion in a large bone, because a delayed diagnosis may result in severe consequences.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="conflict">
<label>Declaration of Conflicting Interests</label>
<p>The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.</p>
</fn>
<fn fn-type="financial-disclosure">
<label>Funding</label>
<p>The author(s) received no financial support for the research, authorship, and/or publication of this article.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="bibr1-1066896912453202">
<label>1.</label>
<citation citation-type="book">
<person-group person-group-type="editor">
<name><surname>Fletcher</surname><given-names>CDM</given-names></name>
<name><surname>Unni</surname><given-names>KK</given-names></name>
<name><surname>Mertens</surname><given-names>F</given-names></name>
</person-group>, eds. <source>World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone</source>. <publisher-loc>Lyon, France</publisher-loc>: <publisher-name>IARC Press</publisher-name>; <year>2002</year>.</citation>
</ref>
<ref id="bibr2-1066896912453202">
<label>2.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hameed</surname><given-names>M</given-names></name>
<name><surname>Dorfman</surname><given-names>H.</given-names></name>
</person-group> <article-title>Primary malignant bone tumors—recent developments</article-title>. <source>Semin Diagn Pathol</source>. <year>2011</year>;<volume>28</volume>:<fpage>86</fpage>-<lpage>101</lpage>.</citation>
</ref>
<ref id="bibr3-1066896912453202">
<label>3.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Heare</surname><given-names>T</given-names></name>
<name><surname>Hensley</surname><given-names>MA</given-names></name>
<name><surname>Dell’Orfano</surname><given-names>S.</given-names></name>
</person-group> <article-title>Bone tumors: osteosarcoma and Ewing’s sarcoma</article-title>. <source>Curr Opin Pediatr</source>. <year>2009</year>; <volume>21</volume>:<fpage>365</fpage>-<lpage>372</lpage>.</citation>
</ref>
<ref id="bibr4-1066896912453202">
<label>4.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Muscolo</surname><given-names>L</given-names></name>
<name><surname>Campaner</surname><given-names>G</given-names></name>
<name><surname>Aponte-Tinao</surname><given-names>L</given-names></name>
<name><surname>Ayerza</surname><given-names>M</given-names></name>
<name><surname>Santini-Araujo</surname><given-names>E.</given-names></name>
</person-group> <article-title>Epiphyseal primary location for osteosarcoma and Ewing sarcoma in patients with open physis</article-title>. <source>J Pediatr Orthop</source>. <year>2003</year>;<volume>23</volume>:<fpage>542</fpage>-<lpage>545</lpage>.</citation>
</ref>
<ref id="bibr5-1066896912453202">
<label>5.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kowalczyk</surname><given-names>B</given-names></name>
<name><surname>Lejman</surname><given-names>T</given-names></name>
<name><surname>Drabik</surname><given-names>G</given-names></name>
<name><surname>Załęska-Czepko</surname><given-names>E.</given-names></name>
</person-group> <article-title>Primary epiphyseal localization of primitive neuroectodermal tumor in a child</article-title>. <source>Eur J Radiol</source>. <year>2011</year>;<volume>78</volume>:<fpage>e77</fpage>-<lpage>e80</lpage>.</citation>
</ref>
<ref id="bibr6-1066896912453202">
<label>6.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hovy</surname><given-names>L.</given-names></name>
</person-group> <article-title>Tumoren der Epiphyse</article-title>. <source>Z Orthop Ihre Grenzgeb</source>. <year>1996</year>;<volume>134</volume>:<fpage>413</fpage>-<lpage>417</lpage>.</citation>
</ref>
<ref id="bibr7-1066896912453202">
<label>7.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Villas</surname><given-names>C</given-names></name>
<name><surname>San Julián</surname><given-names>M.</given-names></name>
</person-group> <article-title>Ewing’s tumor of the spine: report on seven cases including one with a 10-year follow-up</article-title>. <source>Eur Spine J</source>. <year>1996</year>;<volume>5</volume>:<fpage>412</fpage>-<lpage>417</lpage>.</citation>
</ref>
<ref id="bibr8-1066896912453202">
<label>8.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Ilić</surname><given-names>I</given-names></name>
<name><surname>Manojlović</surname><given-names>S</given-names></name>
<name><surname>Cepulić</surname><given-names>M</given-names></name>
<name><surname>Orlić</surname><given-names>D</given-names></name>
<name><surname>Seiwerth</surname><given-names>S.</given-names></name>
</person-group> <article-title>Osteosarcoma and Ewing’s sarcoma in children and adolescents: retrospective clinicopathological study</article-title>. <source>Croat Med J</source>. <year>2004</year>; <volume>45</volume>:<fpage>740</fpage>-<lpage>745</lpage>.</citation>
</ref>
<ref id="bibr9-1066896912453202">
<label>9.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Enneking</surname><given-names>WF</given-names></name>
<name><surname>Kagan</surname><given-names>A.</given-names></name>
</person-group> <article-title>Transepiphyseal extension of osteosarcoma: incidence, mechanism, and implications</article-title>. <source>Cancer</source>. <year>1978</year>;<volume>41</volume>:<fpage>1526</fpage>-<lpage>1537</lpage>.</citation>
</ref>
<ref id="bibr10-1066896912453202">
<label>10.</label>
<citation citation-type="book">
<person-group person-group-type="author">
<name><surname>Greenspan</surname><given-names>A</given-names></name>
<name><surname>Gernot</surname><given-names>J</given-names></name>
<name><surname>Remagen</surname><given-names>W</given-names></name>
</person-group>. <article-title>Round cell lesions</article-title>. In: <source>Differential Diagnosis in Orthopaedic Oncology</source>. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lippincott Wiliams &amp; Wilkins</publisher-name>; <year>2007</year>.</citation>
</ref>
<ref id="bibr11-1066896912453202">
<label>11.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Murphey</surname><given-names>MD</given-names></name>
<name><surname>Gibson</surname><given-names>MS</given-names></name>
<name><surname>Jennings</surname><given-names>BT</given-names></name>
<name><surname>Crespo-Rodriguez</surname><given-names>AM</given-names></name>
<name><surname>Famburg-Smith</surname><given-names>J</given-names></name>
<name><surname>Gajewski</surname><given-names>DA.</given-names></name>
</person-group> <article-title>From the archives of the AFIP: imaging of synovial sarcoma with radiologic-pathologic correlation</article-title>. <source>Radiographics</source>. <year>2006</year>;<volume>26</volume>:<fpage>1543</fpage>-<lpage>1565</lpage>.</citation>
</ref>
<ref id="bibr12-1066896912453202">
<label>12.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Hwang</surname><given-names>S.</given-names></name>
</person-group> <article-title>Imaging of lymphoma of the musculoskeletal system</article-title>. <source>Radiol Clin North Am</source>. <year>2008</year>;<volume>46</volume>:<fpage>379</fpage>-<lpage>396</lpage>.</citation>
</ref>
<ref id="bibr13-1066896912453202">
<label>13.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Granter</surname><given-names>SR</given-names></name>
<name><surname>Renshaw</surname><given-names>AA</given-names></name>
<name><surname>Fletcher</surname><given-names>CD</given-names></name>
<name><surname>Bhan</surname><given-names>AK</given-names></name>
<name><surname>Rosenberg</surname><given-names>AE.</given-names></name>
</person-group> <article-title>CD99 reactivity in mesenchymal chondrosarcoma</article-title>. <source>Hum Pathol</source>. <year>1996</year>;<volume>27</volume>:<fpage>1273</fpage>-<lpage>1276</lpage>.</citation>
</ref>
<ref id="bibr14-1066896912453202">
<label>14.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Folpe</surname><given-names>AL</given-names></name>
<name><surname>Goldblum</surname><given-names>JR</given-names></name>
<name><surname>Rubin</surname><given-names>BP</given-names></name><etal/>
</person-group>. <article-title>Morphologic and inmunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases</article-title>. <source>Am J Surg Pathol</source>. <year>2005</year>;<volume>29</volume>:<fpage>1025</fpage>-<lpage>1033</lpage>.</citation>
</ref>
<ref id="bibr15-1066896912453202">
<label>15.</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name><surname>Kissane</surname><given-names>JM</given-names></name>
<name><surname>Askin</surname><given-names>FB</given-names></name>
<name><surname>Foulkes</surname><given-names>M</given-names></name>
<name><surname>Stratton</surname><given-names>LB</given-names></name>
<name><surname>Shirley</surname><given-names>SF.</given-names></name>
</person-group> <article-title>Ewing’s sarcoma of bone: clinicopathologic aspects of 303 cases from the Intergroup Ewing’s Sarcoma Study</article-title>. <source>Hum Pathol</source>. <year>1983</year>;<volume>14</volume>:<fpage>773</fpage>-<lpage>779</lpage>.</citation>
</ref>
</ref-list>
</back>
</article>